These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2306475)

  • 21. Inhibition of dopamine-beta-hydroxylase by carnosine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Tohoku J Exp Med; 1975 Sep; 117(1):101-2. PubMed ID: 1188926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY TROPOLONE AND OTHER CHELATING AGENTS.
    GOLDSTEIN M; LAUBER E; MCKEREGHAN MR
    Biochem Pharmacol; 1964 Jul; 13():1103-6. PubMed ID: 14201135
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of the insect enzyme, tyramine beta-monooxygenase, reveals differences from the mammalian enzyme, dopamine beta-monooxygenase.
    Hess CR; McGuirl MM; Klinman JP
    J Biol Chem; 2008 Feb; 283(6):3042-3049. PubMed ID: 18032384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further studies on irreversible inhibition of dopamine-beta-hydroxylase by cysteine.
    Izumi H; Hayakari M; Ozawa H
    Tohoku J Exp Med; 1976 Apr; 118(4):373-80. PubMed ID: 936210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human serum dopamine-beta-hydroxylase: purification, molecular weight, presence of sugars and kinetic properties.
    Miras-Portugal MT; Aunis D; Mandel P
    Biochimie; 1975; 57(6-7):669-75. PubMed ID: 812555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Garvey E; Hilbert EL; Faulkner WA; Flaim KE; Sawyer JL; Berkowitz BA
    J Med Chem; 1986 Dec; 29(12):2465-72. PubMed ID: 3783606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic and e.p.r. studies of cyanide and azide binding to the copper sites of dopamine (3,4-dihydroxyphenethylamine) beta-mono-oxygenase.
    Blackburn NJ; Collison D; Sutton J; Mabbs FE
    Biochem J; 1984 Jun; 220(2):447-54. PubMed ID: 6331417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase.
    McCarthy JR; Matthews DP; Broersma RJ; McDermott RD; Kastner PR; Hornsperger JM; Demeter DA; Weintraub HJ; Whitten JP
    J Med Chem; 1990 Jul; 33(7):1866-73. PubMed ID: 2362264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine adrenal medullary dopamine beta-hydroxylase: purification by affinity chromatography, kinetic studies and presence of essential histidyl residues.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochim Biophys Acta; 1973 Dec; 327(2):313-27. PubMed ID: 4778938
    [No Abstract]   [Full Text] [Related]  

  • 30. Inactivation of dopamine beta-hydroxylase by p-cresol: evidence for a second, minor site of covalent modification at tyrosine 357.
    Southan C; DeWolf WE; Kruse LI
    Biochim Biophys Acta; 1990 Feb; 1037(2):256-8. PubMed ID: 2306476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of inactivation of dopamine beta-hydroxylase by hydrazines.
    Fitzpatrick PF; Villafranca JJ
    J Biol Chem; 1986 Apr; 261(10):4510-8. PubMed ID: 3007460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of dopamine-beta-hydroxylase by hydralazine.
    Liu TZ; Shen JT; Loken HF
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):294-7. PubMed ID: 4812865
    [No Abstract]   [Full Text] [Related]  

  • 33. A slow-tight binding inhibitor of dopamine beta-monooxygenase: a transition state analogue for the product release step.
    Dharmasena SP; Wimalasena DS; Wimalasena K
    Biochemistry; 2002 Oct; 41(41):12414-20. PubMed ID: 12369831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Ross ST; Wawro J; Wise M; Flaim KE; Sawyer JL; Erickson RW
    J Med Chem; 1987 Mar; 30(3):486-94. PubMed ID: 3820219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
    Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
    Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Phenylpropenes as mechanism-based inhibitors of dopamine beta-hydroxylase: evidence for a radical mechanism.
    Fitzpatrick PF; Flory DR; Villafranca JJ
    Biochemistry; 1985 Apr; 24(9):2108-14. PubMed ID: 3995005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine -hydroxylase of bovine adrenal medullae. A rapid purification procedure.
    Foldes A; Jeffrey PL; Preston BN; Austin L
    Biochem J; 1972 Mar; 126(5):1209-17. PubMed ID: 4672506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of human serum dopamine-beta-hydroxylase levels by radioimmunoassay and enzymatic assay.
    Rush RA; Thomas PE; Nagatsu T; Udenfriend S
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):872-4. PubMed ID: 4522796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deduction of kinetic mechanism in multisubstrate enzyme reactions from tritium isotope effects. Application to dopamine beta-hydroxylase.
    Klinman JP; Humphries H; Voet JG
    J Biol Chem; 1980 Dec; 255(24):11648-51. PubMed ID: 7002926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.